Best Evidence Topics
  • Send this BET as an Email
  • Make a Comment on this BET

Does Clopidogrel Increase Morbidity and Mortality After Minor Head Injury

Three Part Question

In a patient with a [head injury], does concurrent [treatment with clopidogrel] [increase morbidity and mortality]?

Clinical Scenario

A 78-year old male presents to the Emergency Department in a coma two days after a minor head injury. You note he is taking clopidogrel for treatment of his ischaemic heart disease. CT scan shows a large sub-dural haematoma. You wonder whether the clopidogrel has contributed to the development of this haematoma?

Search Strategy

Medline: 1950 2007 April week 1
[(brain injury.mp. or exp Brain Injuries/) OR (craniocerebral trauma.mp. or exp Craniocerebral Trauma/) OR (head injur$.mp.)] AND [(antithromb$.mp.exp Platelet Aggregation Inhibitors/ or clopidogrel.mp.) OR (platelet aggregation inhibitor$.mp.)] limit to (humans and english language)
EMBASE: [cranio-cerebral trauma OR head injury] AND [clopidogrel OR antithrombocytic agent] LIMIT to humans

Search Outcome

Medline yielded 113 papers,EMBASE 58. 4 were relevant.

Relevant Paper(s)

Author, date and country Patient group Study type (level of evidence) Outcomes Key results Study Weaknesses
Jones et al.
2006
USA
43 injured patients, over the age of 50, documented to be taking clopidogrel (P), matched to controls (C) with similar mechanisms of injury, age, sex and ISS. 25 head injuries in group P (9 SDH/EDH) and 21 head injuries in group C (10 SDH/EDH)Retrospective chart reviewDeath3/9 (33%) in P vs. 4/10 (40%) in C, NSSmall numbers Retrospective review Not isolated minor head injury: patients reported were classed as having major head injuries.
Need for surgery6/9 (66%) in P vs. 2/10 (20%), p=0.055
Blood/platelet transfusion11 in P vs. 3 in C, p<0.015
Rebleed5/9 (55%) vs. 1/10 (10%), p=0.005
ICU stay5.8 days for P vs. 5.3 days for C, NS
Hospital stay11 days for P vs. 10.5 days for C, NS
Ohm et al.
2005
USA
90 patients, 50 years or older, taking anti-platelet agents with a traumatic intra-cranial haemorrhage matched to 89 control patients with similar ISS, GCS, age and sex not taking anti-platelet agents.Retrospective chart reviewMortality21/90 (23%) study gp vs.8/89 (8.9%) controls, p=0.016.Retrospective review. Different anti-platelet agents used. Co-morbidity rates were different in the 2 groups. 71% of study gp had 3 or more co-morbidities vs. 35% in the control gp (p<0.001). Small numbers.
Need for surgery21/90 (23%) vs. 17/89 (19%), NS
Blood transfusion20/90 (22%) vs. 13/89 (15%), p=0.262
Platelet transfusion24/90(27%) vs. 5/89 (6%), p=0.001
FFP transfusion13/90 (14%) vs. 3/89 (3%), p=0.009
Mina et al.
2002
USA
37 patients admitted with intracerebral injury and on anticoagulants (including clopidogrel) and 37 matched controls.Retrospective analysisDeath14/37 (38%) vs. 3/37 (8%) in controls, p=0.006Retrospective study. Only 2 patients were on clopidogrel.
Rozzelle et al.
1995
USA
Patients aged 65 years or over admitted with a subdural haematoma.Retrospective cohortRisk factor for death (logistic regression)Anti-thrombotic medication use was not associated with hospital mortality.30% had no documented trauma. Only 31 patients were on anti-platelet treatment.

Comment(s)

The clinical impression is that concomitant with the increase in the number of patients taking clopidogrel, there is a rise in the number of patients on clopidogrel presenting with significant intra-cranial haemorrhage after minor head injury. Whether clopidogrel contributes to the development of the intra-cranial haemorrhage is unclear and there is currently very little evidence addressing this subject. This is perhaps not surprising considering that clopidogrel is a relatively new drug and even with older established anticoagulant and anti-thrombotic drugs such as warfarin and aspirin, there is continued debate about the quality and quantity of evidence delineating their exact role in the development of intra-cranial haemorrhage following head injury.

Clinical Bottom Line

There is insufficient evidence to firmly state that clopidogrel worsens outcomes in patients with minor head injury.

References

  1. Jones K, Sharp C, Mangram A, Dunn EL. The Effects of Preinjury Clopidogrel Use On Older Trauma Patients with Head Injuries. American Journal of Surgery 2006;192:743-745
  2. Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of Antiplatelet Agents On Outcomes for Elderly Patients With Traumatic Intracranial Hemorrhage. Journal of Trauma 2005;58:518-522
  3. Mina AA. Knipfer JF. Park DY. Bair HA. Howells GA. Bendick PJ. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. Journal of Trauma-Injury Infection & Critical Care. 2002, 53(4):668-72.
  4. Rozzelle CJ. Wofford JL. Branch CL. Predictors of hospital mortality in older patients with subdural hematoma. Journal of the American Geriatrics Society. 1995, 43(3):240-4.